Sandbox Reserved 1122
From Proteopedia
(Difference between revisions)
Line 24: | Line 24: | ||
BH3-only proteins which belong to the Bcl-2 family activate pro-apoptotic proteins such as Bcl-2-associated X protein (Bax) or Bcl-2 antagonist/killer-1 (Bak) at the mitochondrion. When Bax or Bak are activated, they homo-oligomerize and form the pores in the outer mitochondrial membrane which are necessary for the pro-apoptotic molecules (including second mitochondria-derived activator of caspase and cytochrome c) to escape. Then cytochrome c leads to the activation of caspases which are actually proteases that degrade the key proteins of the cell. | BH3-only proteins which belong to the Bcl-2 family activate pro-apoptotic proteins such as Bcl-2-associated X protein (Bax) or Bcl-2 antagonist/killer-1 (Bak) at the mitochondrion. When Bax or Bak are activated, they homo-oligomerize and form the pores in the outer mitochondrial membrane which are necessary for the pro-apoptotic molecules (including second mitochondria-derived activator of caspase and cytochrome c) to escape. Then cytochrome c leads to the activation of caspases which are actually proteases that degrade the key proteins of the cell. | ||
- | On the other hand, Bcl-2 may prevent the activation and homo-oligomerization of Bax and Bak thus blocking the cell death. This is achieved by sequestering BH3-only proteins or activated and monomeric Bax and Bak. BH1 and BH2 are essential for Bcl-2/Bax heterodimer formation. The conservation of each amino acid seems to be very important to this interaction. <ref>[http://www.nature.com.scd-rproxy.u-strasbg.fr/nature/journal/v369/n6478/pdf/369321a0.pdf BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax] </ref><ref>[http://jcs.biologists.org/content/122/4/437 Control of mitochondrial apoptosis by the Bcl-2 family] </ref> | + | On the other hand, Bcl-2 may prevent the activation and homo-oligomerization of Bax and Bak thus blocking the cell death. This is achieved by sequestering BH3-only proteins or activated and monomeric Bax and Bak. <scene name='71/719863/Scenebh1/1'>BH1</scene> and <scene name='71/719863/Scenebh2/1'>BH2</scene> are essential for Bcl-2/Bax heterodimer formation. The conservation of each amino acid seems to be very important to this interaction. <ref>[http://www.nature.com.scd-rproxy.u-strasbg.fr/nature/journal/v369/n6478/pdf/369321a0.pdf BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax] </ref><ref>[http://jcs.biologists.org/content/122/4/437 Control of mitochondrial apoptosis by the Bcl-2 family] </ref> |
Therefore, the neutralization of Bcl-2 is required for eficient cell-death. BH3 proteins Bad, Bim and Puma bind Bcl-2 and disable its anti-apoptotic activity. BH3 peptides occupy the hydrophobic pocket of Bcl-2 and the sequestered pro-apoptotic proteins are released. <ref>[http://www.cell.com/molecular-cell/fulltext/S1097-2765(05)01040-3 Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function]</ref> <ref> [http://www.cell.com/cancer-cell/fulltext/S1535-6108(02)00127-7 Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics] </ref> | Therefore, the neutralization of Bcl-2 is required for eficient cell-death. BH3 proteins Bad, Bim and Puma bind Bcl-2 and disable its anti-apoptotic activity. BH3 peptides occupy the hydrophobic pocket of Bcl-2 and the sequestered pro-apoptotic proteins are released. <ref>[http://www.cell.com/molecular-cell/fulltext/S1097-2765(05)01040-3 Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function]</ref> <ref> [http://www.cell.com/cancer-cell/fulltext/S1535-6108(02)00127-7 Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics] </ref> |
Revision as of 16:43, 28 January 2016
This Sandbox is Reserved from 15/12/2015, through 15/06/2016 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1120 through Sandbox Reserved 1159. |
To get started:
More help: Help:Editing |
HUMAN BCL-2, ISOFORM1
|
References
- β Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- β Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- β Solution structure of the antiapoptotic protein bcl-2
- β Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP3 Receptor
- β BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
- β Control of mitochondrial apoptosis by the Bcl-2 family
- β Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function
- β Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
- β The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
- β Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
- β Bcl-2 and Bcl-XL Regulate Proinflammatory Caspase-1 Activation by Interaction with NALP1